18,881 reports of this reaction
3.5% of all METFORMIN ER 750 MG reports
#1 most reported adverse reaction
NAUSEA is the #1 most commonly reported adverse reaction for METFORMIN ER 750 MG, manufactured by Granules Pharmaceuticals Inc.. There are 18,881 FDA adverse event reports linking METFORMIN ER 750 MG to NAUSEA. This represents approximately 3.5% of all 532,492 adverse event reports for this drug.
Patients taking METFORMIN ER 750 MG who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among METFORMIN ER 750 MG users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for METFORMIN ER 750 MG:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 18,881 FDA reports for METFORMIN ER 750 MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.5% of all adverse event reports for METFORMIN ER 750 MG, making it one of the most commonly reported side effect.
If you experience nausea while taking METFORMIN ER 750 MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.